The impact of serum glucose on clinical outcomes in patients hospitalized with community-acquired pneumonia

Wisconsin Medical Journal

Volumn 110, Issue 1, 2011, Pages 14-20

  Godar, Desiree A ^a,b   Kumar, David R ^a,b   Schmelzer, Kate M ^a   Talsness, Stephen R ^a   Liang, Hong ^a   Schmelzer, John R ^a   Mazza, Joseph J ^a   Yale, Steven H ^a  

^a MARSHFIELD CLINIC   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT TRANSPORT; PREDICTION; RISK FACTOR; SCREENING TEST;

AGED; BLOOD GLUCOSE; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; LENGTH OF STAY; MALE; PNEUMONIA; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 79957665580     PISSN: 10981861     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Met. 2002; 87(3): 978-982.
2. Williams LS, Rotich J, Fineberg N, et al. Effect of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology. 2002; 59(1): 67-71.
3. Hadjadj S, Coisene D, Mauco G, et al. Prognostic value of admission plasma glucose and HbA in acute myocardial infarction. Diabet Med. 2004; 21(4): 305-310.
4. Sala J, Masia R, Gonzalez de Molina FJ, et al. Short-term mortality of myocardial infarction patients with diabetes or hyperglycemia during admission. J Epidemiol Community Health. 2002; 56(9): 707-712.
5. Yendamuri S, Fulda GJ, Tinkoff GH. Admission hyperglycemia as a prognostic indicator in trauma. J Trauma. 2003; 55(1): 33-38.
6. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA. 2003; 290(15): 2041-2047.
7. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc. 2003; 78(12): 1471-1478.
8. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006; 354(5): 449-461.
9. Gabbanelli V Pantanetti S, Donati A, Principi T, Pelaia P. Correlation between hyperglycemia and mortality in a medical and surgical intensive care unit. Minerva Anesthesiol. 2005; 71(11): 717-725.
10. Christiansen C, Toft P, Jørgensen HS, Andersen SK, Tønnesen E. Hyperglycemia and mortality in critically ill patients: a prospective study. Intensive Care Med. 2004; 30(8): 1685-1688.
11. Alvarez-Sabin J, Molina CA, Montaner J, et al. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator-treated patients. Stroke. 2003; 34(5): 1235-1241.
12. McAlister FA, Majumdar SR, Blitz S, Rowe BH, Romney J, Marrie TJ. The relation between hyperglycemia and outcomes in 2471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care. 2005; 28(4): 810-815.
13. Latham R, Lancaster AD, Covington JF, Pirolo JS, Thomas CS. The association of diabetes and glucose control with surgical-site infection among cardiothoracic surgery patients. Infect Control Hosp Epidemiol. 2001; 22(10): 607-612.
14. Golden SH, Peart-Vigilance C, Kao WH, Brancati FL. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care. 1999; 22(9): 1408-1414.
15. Estrada CA, Young JA, Nifong LW, Chitwood WR Jr. Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting. Ann Thorac Surg. 2003; 75(5): 1392-1399.
16. Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, Genetet B. Impaired leukocyte functions in diabetic patients. Diabet Med. 1997; 14(1): 29-34.
17. Llorente L, De La Fuente H, Richaud-Patin Y, et al. Innate immune response mechanisms in non-insulin dependent diabetes mellitus patients assessed by flow cytoenzymlogy. Immunol Lett. 2000; 74(3): 239-244.
18. Strieter RM, Belperio JA, Keane MP. Host innate defenses in the lung: the role of cytokines. Curr Opin Infect Dis. 2003; 16(3): 193-198.
19. Wunderink RG, Waterer GW. Community-acquired pneumonia: pathophysiology and host factors with focus on possible new approaches to management of lower respiratory tract infections. Infect Dis Clin North Am. 2004; 18(4): 743-759.
20. Mason CM, Nelson S. Pulmonary host defenses and factors predisposing to lung infection. Clin Chest Med. 2005; 26(1): 11-17.
21. Mandell LA, Bartlett JG, Dowell SF, et al. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis. 2003; 37(11): 1405-1433.
22. Bartlett JG, Breiman RF, Mandell LA, File TM Jr. Community-acquired pneumonia in adults: guidelines for management. The Infectious Disease Society of America. Clin Infect Dis. 1998; 26(4): 811-838.
23. Bartlett JG, Dowell SF, Mandell LA, File Jr TM, Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis. 2000; 31(2): 347-382.
24. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997; 336(4): 243-250.
25. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987; 40(5): 373-383.
26. El Solh A, Pineda L, Bouquin P, Mankowski C. Determinants of short and long term functional recovery after hospitalization for community-acquired pneumonia in the elderly: role of inflammatory markers. BMC Geriatr. 2006: 6; 12.
27. Kornum JB, Thomsen RW, Riis A, Lervang HH, Schonheyder HC, Sørensen HT. Type 2 diabetes and pneumonia outcomes: a population-based cohort study. Diabetes Care. 2007; 30(9): 2251-2257.
28. Castellanos MR, Fadel DA, Seminara DP. Brief report: glucose control in nondiabetic elderly patients with pneumonia may be an overlooked therapeutic target. Clin Geriatr. 2008; 16(5): 25-26.
29. Inzucchi SE. Clinical practice: management of hyperglycemia in the hospital setting. N Engl J Med. 2006; 355(18): 1903-1911.
30. ACE/ADA Task Force on Inpatient Diabetes. American College of Endocrinology and American Diabetes Association consensus statement on inpatient diabetes and glycemic control. Diabetes Care. 2006; 29(8): 1955-1962.
31. Gamble JM, Eurich DT, Marrie TJ, Majumdar SR. Admission hypoglycemia and increased mortality in patients hospitalized with pneumonia. Am J Med. 2010; 123(6): 556.e11-6
32. Mortensen EM, Garcia S, Leykum L, Nakashima B, Restrepo MI, Anzueto A. Association of hypoglycemia with mortality for subjects hospitalized with pneumonia. Am J Med Sci. 2010; 339(3): 239-243.
33. Yu KT, Wyer PC. Evidence-based emergency medicine/critically appraised topic. evidence behind the 4-hour rule for initiation of antibiotic therapy in communityacquired pneumonia. Ann Emerg Med. 2008; 51(5): 651-662.
34. Martínez R, Reyes S, Lorenzo MJ, Menéndez R. Impact of guidelines on outcome: the evidence. Sem Resp Crit Care Med. 2009; 30(2): 172-178.
35. Doruk S, Tertemiz KC, Kömüs N, Ucan ES, Kilinc O, Sevinc C. Community acquired pneumonia and direct hospital cost. Tuberk Toraks. 2009; 57(1): 48-55.
36. Brown PD. Adherence to guidelines for community-acquired pneumonia: does it decrease cost of care? Pharmacoeconomics. 2004; 22(7): 413-420.
37. Niederman MS. What is the prognosis for using the pneumonia severity index to make site-of-care decisions in community-acquired pneumonia? Chest. 2003; 124(6): 2051-2053.
38. Halm EA, Atlas SJ, Borowksy LH, Benzer TI, Singer DE. Change in physician knowledge and attitudes after implementation of a pneumonia practice guideline. J Gen Intern Med. 1999; 14(11): 688-694.
39. Vogelzang M, van der Horst IC, Nijsten MW. Hyperglycaemic index as a tool to assess glucose control: a retrospective study. Crit Care. 2004; 8(3): R122-127.